Cite

    Thomas M MacDonald et al.. “Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT).” BMJ open, vol. 3, no. 1, 2013, p. . http://access.bl.uk/ark:/81055/vdc_100137784173.0x000008